Skip to main content
. 2021 Mar 18;106(7):1794–1804. doi: 10.3324/haematol.2020.268839

Table 4.

Risk factors influencing treatment failure (relapse or NRM) after allogeneic HSCT.

graphic file with name 1061794.tab4.jpg